SHL Medical acquires Swiss toolmaking company SMC Mould Innovation

SHL Medical, a leading provider of drug delivery solutions worldwide, furthers its expansion strategy by acquiring SMC Mould Innovation, a Swiss manufacturer specialising in high-performance injection molding tools, based in Hallau. 

SHL Medical, a leading provider of drug delivery solutions worldwide, furthers its expansion strategy by acquiring SMC Mould Innovation, a Swiss manufacturer specialising in high-performance injection molding tools, based in Hallau. Building on its recent purchase of LCA Automation, this acquisition further strengthens SHL’s vertical manufacturing capabilities in Switzerland as it gears up for autoinjector production in Zug starting 2026.

SHL Medical (hereinafter referred to as “SHL”), headquartered in Zug, Switzerland, has announced the acquisition of SMC Mould Innovation (hereinafter referred to as “SMC”), a leading Swiss developer and manufacturer of high-performance injection molding tools located in Schaffhausen, Switzerland.

This acquisition marks SHL’s third acquisition within a year as part of its expansion strategy, following the acquisitions of LCA Automation in Switzerland and Superior Tooling in the United States. The company’s strategy aims to meet the increasing market demand for autoinjectors, expand SHL’s global production capabilities, and enhance competencies across the value chain. Integrating SMC will strengthen SHL’s vertical manufacturing capabilities on a global level, notably at its upcoming manufacturing site in Zug, currently under construction.

Both SHL and SMC share extensive expertise in the development and manufacturing of injection molding tools, synergizing their efforts to provide customers with efficient and innovative solutions.

Ulrich Faessler, Chairman and CEO of SHL Medical, highlights, “With the acquisition of SMC, we fortify our market leadership position, support our global growth, and ensure sustained market responsiveness. By leveraging SMC’s expertise, we reinforce one of our key differentiators – the complete in-house production of our products and solutions.”

Konrad Stadelmann and Paul Conrad, Managing Directors of SMC Mould Innovation, add, “As a smaller enterprise, we eagerly anticipate contributing our skills on a global scale, leveraging our valuable Swiss expertise to deliver unparalleled precision and manufacturing quality for both existing and new customers.”